Alterity Therapeutics Ltd Adr (ATHE)

01:58 AM

Alterity Therapeutics announces ATH434 Phase 2 trial results - MSN

01:58 AM

Jan 29, 2025

Alterity Therapeutics Reports Promising Phase 2 Results for MSA Drug ATH434 - TipRanks

Jan 29, 2025

Jan 28, 2025

Alterity Therapeutics announces trading halt - Investing.com

Jan 28, 2025

Jan 27, 2025

Alterity Therapeutics Initiates Trading Halt Pending Phase II Trial Results - TipRanks

Jan 27, 2025

Jan 24, 2025

Alterity Therapeutics reports quarterly activities - Investing.com

Jan 24, 2025

Jan 24, 2025

Alterity Therapeutics reports quarterly activities By Investing.com - Investing.com UK

Jan 24, 2025

Jan 23, 2025

Alterity Therapeutics Advances ATH434 Clinical Trials with Promising Data - TipRanks

Jan 23, 2025

Jan 21, 2025

Alterity Therapeutics Reports Key Advances and Anticipates Milestones in 2025 - TipRanks

Jan 21, 2025

Jan 07, 2025

Opthea reports positive Phase 1b DME trial results - Investing.com

Jan 07, 2025

Dec 04, 2024

ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns - Stockhead

Dec 04, 2024

Nov 23, 2024

Alterity Therapeutics reports annual general meeting results By Investing.com - Investing.com South Africa

Nov 23, 2024

Nov 22, 2024

Alterity Therapeutics reports annual general meeting results - Investing.com India

Nov 22, 2024

Nov 19, 2024

Alterity Therapeutics announces change in company secretary - Investing.com

Nov 19, 2024

Nov 19, 2024

Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary - Yahoo Finance

Nov 19, 2024

Nov 15, 2024

Opthea adds Kathy Connell to Board of Directors - Investing.com

Nov 15, 2024

Oct 15, 2024

Alterity Therapeutics to join Maxim Healthcare Summit - Investing.com

Oct 15, 2024

Oct 14, 2024

Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - GlobeNewswire Inc.

Oct 14, 2024

Oct 04, 2024

Alterity Therapeutics announces change in share registry - Investing.com

Oct 04, 2024

Oct 04, 2024

Alterity Therapeutics announces change in share registry By Investing.com - Investing.com UK

Oct 04, 2024

Oct 01, 2024

Opthea Ltd stock soars to 52-week high, hits $4.47 - Investing.com India

Oct 01, 2024

Oct 01, 2024

Alterity Therapeutics names new CFO - Investing.com India

Oct 01, 2024

Sep 26, 2024

Alterity Therapeutics discloses annual report for 2024 - Investing.com

Sep 26, 2024

Jun 12, 2024

ATHEAlterity Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Jun 12, 2024

Feb 15, 2024

Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners - Stockhead

Feb 15, 2024

Aug 17, 2023

Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money ... - Stockhead

Aug 17, 2023

Jan 06, 2023

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation) - PR Newswire

Jan 06, 2023

Mar 19, 2020

The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection - Yahoo Finance

Mar 19, 2020

Jan 03, 2020

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance

Jan 03, 2020